Home > Annual Financials > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES Financial Statement Analysis
[BOM: 524715|NSE : SUNPHARMA]

The Revenues of SUN PHARMACEUTICAL INDUSTRIES have increased by 10.51% YoY .
The Earnings Per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES has increased by 14.13 % YoY.
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Annual Financial Results
[BOM: 524715|NSE : SUNPHARMA]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹48,497 Cr₹43,886 Cr₹38,654 Cr₹33,498 Cr₹32,838 Cr
Expenses ₹35,748 Cr₹32,298 Cr₹28,773 Cr₹25,030 Cr₹25,863 Cr
Operating Profit (Excl OI) ₹12,749 Cr₹11,588 Cr₹9,882 Cr₹8,468 Cr₹6,974 Cr
Other Income ₹1,628 Cr₹694 Cr₹1,437 Cr₹859 Cr₹652 Cr
Interest ₹238 Cr₹172 Cr₹127 Cr₹141 Cr₹303 Cr
Depreciation ₹2,557 Cr₹2,529 Cr₹2,144 Cr₹2,080 Cr₹2,053 Cr
Profit Before Tax ₹11,088 Cr₹9,408 Cr₹4,481 Cr₹2,799 Cr₹5,010 Cr
Profit After Tax ₹9,648 Cr₹8,561 Cr₹3,406 Cr₹2,285 Cr₹4,187 Cr
Consolidated Net Profit ₹9,576 Cr₹8,474 Cr₹3,273 Cr₹2,904 Cr₹3,765 Cr
Earnings Per Share (Rs)₹45.55₹39.91₹35.32₹13.64₹12.10
PAT Margin (%)20.8819.8919.515.073.72
ROE(%)16.1616.1316.467.214.98
ROCE(%)19.8917.6017.249.285.66
Total Debt/Equity(x)0.030.040.110.020.08

Key Financials

Market Cap : ₹ 448,141.3 Cr
Revenue (TTM) : ₹ 58,462.0 Cr
Net Profit(TTM) : ₹ 11,564.5 Cr
EPS (TTM) : ₹ 48.2
P/E (TTM) : 38.8

Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES 2.6% 1.2% 13%
DIVIS LABORATORIES 1.3% -2.1% 3.8%
TORRENT PHARMACEUTICALS 1.5% 0.7% 37.1%
CIPLA 6.1% 2.4% -5.9%
DR REDDYS LABORATORIES 2.6% -0.4% -2.1%
MANKIND PHARMA 7% 2% 7.9%
LUPIN 4% 3.4% 20.4%
ZYDUS LIFESCIENCES 4.8% 7% 13.1%
AUROBINDO PHARMA 8% 4.8% 34.5%


SUN PHARMACEUTICAL INDUSTRIES Revenues
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

10.51 %

5 Yr CAGR

10.24 %

Years Revenues % Change
Mar2025 ₹48,497 Cr
10.51
Mar2024 ₹43,886 Cr
13.53
Mar2023 ₹38,654 Cr
15.39
Mar2022 ₹33,498 Cr
2.01
Mar2021 ₹32,838 Cr -


SUN PHARMACEUTICAL INDUSTRIES Operating Profit
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

10.02 %

5 Yr CAGR

16.28 %

Years Operating Profit % Change
Mar2025 ₹12,749 Cr
10.02
Mar2024 ₹11,588 Cr
17.26
Mar2023 ₹9,882 Cr
16.70
Mar2022 ₹8,468 Cr
21.42
Mar2021 ₹6,974 Cr -

Operating Margins
Y-o-Y

-0.42 %

5 Yr CAGR

5.48 %

Years Operating Margin% % Change
Mar2025 26.29%
-0.42
Mar2024 26.4%
3.29
Mar2023 25.56%
1.11
Mar2022 25.28%
19.02
Mar2021 21.24% -

SUN PHARMACEUTICAL INDUSTRIES Profit After Tax
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

13.01 %

5 Yr CAGR

26.29 %

Years Profit After Tax % Change
Mar2025 ₹9,576 Cr
13.01
Mar2024 ₹8,474 Cr
158.91
Mar2023 ₹3,273 Cr
12.70
Mar2022 ₹2,904 Cr
-22.87
Mar2021 ₹3,765 Cr -

PAT Margins
Y-o-Y

4.98 %

5 Yr CAGR

53.92 %

Years PAT Margin(%) % Change
Mar2025 20.88 %
4.98
Mar2024 19.89 %
1.95
Mar2023 19.51 %
284.81
Mar2022 5.07 %
36.29
Mar2021 3.72 % -

SUN PHARMACEUTICAL INDUSTRIES Earnings Per Share (EPS)
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

14.13 %

5 Yr CAGR

39.29 %

Years EPS % Change
Mar2025 ₹46
14.13
Mar2024 ₹40
13.00
Mar2023 ₹35
158.94
Mar2022 ₹14
12.73
Mar2021 ₹12 -

SUN PHARMACEUTICAL INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

13.01 %

5 Yr CAGR

36.92 %

Years ROCE % Change
Mar2025 19.89%
13.01
Mar2024 17.6%
2.09
Mar2023 17.24%
85.78
Mar2022 9.28%
63.96
Mar2021 5.66% -

SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Current Share Price : ₹1,867.8
Current MarketCap: ₹ 448,141.3 Cr
Updated EOD on :Jun 23,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

2.6%

1.2%

13%

SENSEX

-0.8%

1.4%

-6.8%

SUN PHARMACEUTICAL INDUSTRIES related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 3.2% 1.4% 9.9%
BSE 200 EQUAL WEIGHT 0.5% 1.6% 3.4%
BSE 1000 0.2% 2.2% -0.4%
BSE 500 0.1% 1.8% -0.8%
BSE INDIA SECTORS LEADERS 0% 0.7% -5.1%
NSE Indices1W1M1Y
NIFTY PHARMA 3.4% 0.4% 13.4%
NIFTY500 HEALTHCARE INDEX 3.2% 0.8% NA
NIFTY HEALTHCARE INDEX 3.2% 0% 10.6%
NIFTY 500 EQUAL WEIGHT 1.3% 3.9% 2.9%
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX 0.8% 2.9% 2.1%

You may also like the below Video Courses


FAQ about SUN PHARMACEUTICAL INDUSTRIES Financials


How the annual revenues of SUN PHARMACEUTICAL INDUSTRIES have changed ?

The Revenues of SUN PHARMACEUTICAL INDUSTRIES have increased by 10.51% YoY .

How the Earnings per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES have changed?

The Earnings Per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES has increased by 14.13 % YoY .